A meta-analysis indicated that the high expression of ZEB1-AS1, as an adverse factor of cancer prognosis, was significantly positively associated with worse differentiation, deeper invasion, earlier metastasis, poorer clinical stage, and shorter survival40. This evidence concerns the gene ZEB1 and cancer.